Radhia Kacher

Huntington’s disease alters human neurodevelopment

C. Duyckaerts, A. Durr, S. Humbert, 2020, Science.

Altered Cholesterol Homeostasis in Huntington’s Disease

J. Caboche, S. Betuing, C. Mounier, 2022, Frontiers in Aging Neuroscience.

Propensity for somatic expansion increases over the course of life in Huntington disease

A. Durr, A. Brice, S. Humbert, 2021, eLife.

CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease.

J. Caboche, L. Venance, F. Saudou, 2019, Brain : a journal of neurology.

[Regulation of cholesterol metabolism is neuroprotective in Huntington's disease].

J. Caboche, S. Betuing, Radhia Kacher, 2020, Medecine sciences : M/S.

CYP46A1 protects against NMDA-mediated excitotoxicity in Huntington's disease: Analysis of lipid raft content.

J. Caboche, M. Potier, P. Vanhoutte, 2018, Biochimie.

Longitudinal Changes of Clinical, Imaging, and Fluid Biomarkers in Preataxic and Early Ataxic Spinocerebellar Ataxia Type 2 and 7 Carriers

Sabrina Sayah, Lina Daghsen, Radhia Kacher, 2024, Neurology.